Cu-V-Kar Genetic Medicine Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 57.42%
- Profit Growth 1014.22%
- Ebitda 238.30%
- Net Worth 73.79%
- Total Assets 14.54%
About Cu-V-Kar Genetic Medicine
Cu-V-Kar Genetic Medicine Private Limited (CGMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 January 2007 and has a history of 18 years and one month. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ramkumar Srinivasan, Muthukaruppan Srinivasan, and Krishnamoorthy Babu serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U02423TN2007PTC061947
- Company No.
061947
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cu-V-Kar Genetic Medicine?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramkumar Srinivasan  | Director | 04-Jan-2007 | Current |
| Muthukaruppan Srinivasan | Director | 04-Jan-2007 | Current |
| Krishnamoorthy Babu | Director | 24-Oct-2020 | Current |
Financial Performance of Cu-V-Kar Genetic Medicine.
Cu-V-Kar Genetic Medicine Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.42% increase. The company also saw a substantial improvement in profitability, with a 1014.22% increase in profit. The company's net worth Soared by an impressive increase of 73.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cu-V-Kar Genetic Medicine?
In 2023, Cu-V-Kar Genetic Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Viencee Pharma Science Private LimitedRamkumar Srinivasan and Muthukaruppan Srinivasan are mutual person
Cu-V-Kar Pharmacuticals Private LimitedRamkumar Srinivasan and Muthukaruppan Srinivasan are mutual person
- Mm Pharma Medicines Private Limited
Ramkumar Srinivasan and Muthukaruppan Srinivasan are mutual person
- Hfa Formulations Private Limited
Ramkumar Srinivasan and Muthukaruppan Srinivasan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cu-V-Kar Genetic Medicine?
Cu-V-Kar Genetic Medicine has a workforce of 95 employees as of Sep 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cu-V-Kar Genetic Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cu-V-Kar Genetic Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
